Development and Evaluation of Chrysin-Phospholipid Complex Loaded Solid Lipid Nanoparticles - Storage Stability and in Vitro Anti-cancer Activity
Overview
Affiliations
Context: Flavonoids show promising anticancer potential but it is limited due to poor solubility.
Objective: The present investigation was to prepare Chrysin-Phospholipid complex loaded solid lipid nanoparticles (Ch-PC-SLNs) for improving its encapsulation as compared to that of Chrysin loaded SLNs (Ch-SLNs) and evaluated for potential increase in the anti-cancer activity against MCF-7 cell line.
Methods: The physiochemical characteristics and release kinetics for Ch-SLNs and Ch-PC-SLNs were evaluated and compared. Storage stability of Ch-PC-SLNs was evaluated up to 3 months. Solid state properties (DSC, XRD) and morphology (AFM) of Ch-PC-SLNs were also studied. In-vitro anticancer activity was investigated by using MTT assay.
Results And Discussion: Ch-PC-SLNs exhibited higher encapsulation efficiency than Ch-SLNs and zero order release kinetics. Ch-PC-SLNs were found to be stable upto 3 months upon lyophilisation with mannitol as cryoprotectant. DSC and XRD study revealed the loss of highly crystalline nature of Chrysin in Ch-PC-SLNs. The Ch-PC-SLNs lead to significantly higher in-vitro anticancer activity than that of bulk Chrysin.
Conclusion: The study concludes that phospholipids complex with Chrysin lead to improve encapsulation, storage stability of SLNs and in vitro anticancer activity.
El-Emam M, Behairy A, Mostafa M, Khamis T, Osman N, Alsemeh A Biol Res. 2024; 57(1):45.
PMID: 38982468 PMC: 11232158. DOI: 10.1186/s40659-024-00521-1.
Patil J, Pawde D, Bhattacharya S, Srivastava S AAPS PharmSciTech. 2024; 25(5):91.
PMID: 38664316 DOI: 10.1208/s12249-024-02813-x.
Elhoseny S, Saleh N, Meshali M AAPS PharmSciTech. 2024; 25(3):54.
PMID: 38443653 DOI: 10.1208/s12249-024-02767-0.
Pant A, Sharma G, Saini S, Kaur G, Jain A, Thakur A Drug Deliv Transl Res. 2023; 14(3):730-756.
PMID: 37768530 DOI: 10.1007/s13346-023-01427-3.
Ranjbar S, Emamjomeh A, Sharifi F, Zarepour A, Aghaabbasi K, Dehshahri A Pharmaceutics. 2023; 15(7).
PMID: 37514130 PMC: 10383758. DOI: 10.3390/pharmaceutics15071944.